Biomarkers in acute heart failure—state of the art

  title={Biomarkers in acute heart failure—state of the art},
  author={Alan S. Maisel and Rajiv Choudhary},
  journal={Nature Reviews Cardiology},
The role of biomarkers in the management of patients with acute heart failure (HF) has evolved rapidly in the past several years. Representing a major burden on health systems, acute HF has increased the need for earlier diagnosis, better risk stratification, and cost-effective treatment to reduce rates of hospitalization. Biomarker-guided diagnosis and treatment have become essential, especially in the acute setting to which the majority of the patients with acute HF initially present. Studies… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 29 extracted citations


Publications referenced by this paper.
Showing 1-10 of 170 references

Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage : a multicenter prospective cohort study

  • T. Nickolas, L.
  • J . Am . Coll . Cardiol .
  • 2012

Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea : results from the BACH ( Biomarkers in Acute Heart Failure ) trial

  • A. Maisel, S.
  • Eur . J . Heart Fail .
  • 2012

Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease

  • Sinning, R C.
  • Circ. J. 75,
  • 2011

Similar Papers

Loading similar papers…